Nautilus Biotechnology, Inc. Depreciation
Nautilus Biotechnology, Inc. (NAUT) reported Depreciation of $300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-28
- Nautilus Biotechnology, Inc. depreciation for the quarter ending 2026-06-30 was $300.00K, a 25.00% decline year-over-year.
- Nautilus Biotechnology, Inc. depreciation for the quarter ending 2026-03-31 was $334.00K, a 28.17% decline year-over-year.
- Nautilus Biotechnology, Inc. depreciation for the quarter ending 2025-12-31 was $352.00K, a 22.98% decline year-over-year.
- Nautilus Biotechnology, Inc. depreciation for the quarter ending 2025-09-30 was $400.00K, a 20.00% decline year-over-year.
- Nautilus Biotechnology, Inc. depreciation for fiscal 2025 was $1.70M, a 15.00% decline from fiscal 2024.
- Nautilus Biotechnology, Inc. depreciation for fiscal 2024 was $2.00M, a 8.17% increase from fiscal 2023.
- Nautilus Biotechnology, Inc. depreciation for fiscal 2023 was $1.85M, a 51.93% increase from fiscal 2022.
- Nautilus Biotechnology, Inc. depreciation for fiscal 2022 was $1.22M, a 19.43% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-07-28 | $606.00K 10-Q · filed 2026-07-28 | $986.00K derived: sum of 3 quarters · filed 2026-07-28 | $1.39M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2026-03-31 | $334.00K 10-Q · filed 2026-04-28 | $686.00K derived: sum of 2 quarters · filed 2026-04-28 | $1.09M derived: sum of 3 quarters · filed 2026-04-28 | $1.49M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-12-31 | $352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $752.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.15M derived: sum of 3 quarters · filed 2026-07-28 | $1.70M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $400.00K 10-Q · filed 2025-10-28 | $800.00K derived: sum of 2 quarters · filed 2026-07-28 | $1.35M 10-Q · filed 2025-10-28 | $1.72M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-06-30 | $400.00K 10-Q · filed 2026-07-28 | $922.00K 10-Q · filed 2026-07-28 | $1.32M derived: sum of 3 quarters · filed 2026-07-28 | $1.82M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-03-31 | $465.00K 10-Q · filed 2026-04-28 | $922.00K derived: sum of 2 quarters · filed 2026-04-28 | $1.42M derived: sum of 3 quarters · filed 2026-04-28 | $1.92M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2024-12-31 | $457.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $957.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.46M derived: sum of 3 quarters · filed 2026-02-26 | $2.00M 10-K · filed 2026-02-26 | $1.98M 10-K · filed 2025-02-27 |
| 2024-09-30 | $500.00K 10-Q · filed 2025-10-28 | $1.00M derived: sum of 2 quarters · filed 2025-10-28 | $1.54M 10-Q · filed 2025-10-28 | $2.07M derived: sum of 4 quarters · filed 2025-10-28 | |
| 2024-06-30 | $500.00K 10-Q · filed 2025-07-31 | $1.03M 10-Q · filed 2025-07-31 | $1.57M derived: sum of 3 quarters · filed 2025-07-31 | $2.07M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-03-31 | $516.00K 10-Q · filed 2025-04-29 | $1.07M derived: sum of 2 quarters · filed 2025-04-29 | $1.57M derived: sum of 3 quarters · filed 2025-04-29 | $1.97M derived: sum of 4 quarters · filed 2025-04-29 | |
| 2023-12-31 | $555.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.05M derived: sum of 2 quarters · filed 2025-02-27 | $1.46M derived: sum of 3 quarters · filed 2025-02-27 | $1.85M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $500.00K 10-Q · filed 2024-10-29 | $900.00K derived: sum of 2 quarters · filed 2024-10-29 | $1.29M 10-Q · filed 2024-10-29 | $1.63M derived: sum of 4 quarters · filed 2024-10-29 | |
| 2023-06-30 | $400.00K 10-Q · filed 2024-07-30 | $826.00K 10-Q · filed 2024-07-30 | $1.13M derived: sum of 3 quarters · filed 2024-07-30 | $1.43M derived: sum of 4 quarters · filed 2024-07-30 | |
| 2023-03-31 | $385.00K 10-Q · filed 2024-04-30 | $731.00K derived: sum of 2 quarters · filed 2024-04-30 | $1.03M derived: sum of 3 quarters · filed 2024-04-30 | $1.33M derived: sum of 4 quarters · filed 2024-04-30 | |
| 2022-12-31 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $646.00K derived: sum of 2 quarters · filed 2024-02-28 | $946.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.22M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $300.00K 10-Q · filed 2023-10-31 | $600.00K derived: sum of 2 quarters · filed 2023-10-31 | $871.00K 10-Q · filed 2023-10-31 | $1.14M derived: sum of 4 quarters · filed 2023-10-31 | |
| 2022-06-30 | $300.00K 10-Q · filed 2023-08-02 | $562.00K 10-Q · filed 2023-08-02 | $844.00K derived: sum of 3 quarters · filed 2023-08-02 | $1.14M derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-03-31 | $281.00K 10-Q · filed 2023-05-02 | $544.00K derived: sum of 2 quarters · filed 2023-05-02 | $844.00K derived: sum of 3 quarters · filed 2023-05-02 | $1.14M derived: sum of 4 quarters · filed 2023-05-02 | |
| 2021-12-31 | $263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $563.00K derived: sum of 2 quarters · filed 2023-02-23 | $863.00K derived: sum of 3 quarters · filed 2023-02-23 | $1.02M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-01 | $600.00K derived: sum of 2 quarters · filed 2022-11-01 | $756.00K 10-Q · filed 2022-11-01 | $1.01M derived: sum of 4 quarters · filed 2022-11-01 | |
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-02 | $479.00K 10-Q · filed 2022-08-02 | $708.00K derived: sum of 3 quarters · filed 2022-08-02 | $908.00K derived: sum of 4 quarters · filed 2022-08-02 | |
| 2021-03-31 | $214.00K 10-Q · filed 2022-05-03 | $408.00K derived: sum of 2 quarters · filed 2022-05-03 | $608.00K derived: sum of 3 quarters · filed 2022-05-03 | $808.00K derived: sum of 4 quarters · filed 2022-05-03 | |
| 2020-12-31 | $194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $394.00K derived: sum of 2 quarters · filed 2022-02-24 | $594.00K derived: sum of 3 quarters · filed 2022-02-24 | $710.00K 10-K · filed 2022-02-24 | |
| 2020-09-30 | $200.00K 10-Q · filed 2021-11-02 | $400.00K derived: sum of 2 quarters · filed 2021-11-02 | $516.00K 10-Q · filed 2021-11-02 | ||
| 2020-06-30 | $200.00K 10-Q · filed 2021-08-10 | $327.00K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |